salicylic acid has been researched along with isoniazid in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (52.63) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Baulard, AR; Biela, A; Blaise, M; Bourbiaux, K; Cantrelle, FX; Déprez, B; Djaout, K; Faïon, L; Flipo, M; Frita, R; Hanoulle, X; Herledan, A; Kremer, L; Leroux, F; Moune, M; Pintiala, C; Piveteau, C; Tanina, A; Vandeputte, A; Willand, N; Wintjens, R | 1 |
| HINSHAW, HC; THOREN, M | 1 |
| CATACCHIO, L; ZUBIANI, M | 1 |
| AWATAGUCHI, S; KANAYA, A; KANNO, I; KOMATSUDA, K; KUMAGAI, T; KUROBANE, T; NIITU, Y; OKA, S; SATO, S; SHOJI, M; SUGAWARA, T; SUZUKI, C; UEDA, H; YAKUWA, E; YAMADA, S | 1 |
| FISCHER, R; WILLI, AV | 1 |
| AAMODT, T | 1 |
| BANG, HO; JACOBSEN, LK; STRANDGAARD, E; YDE, H | 1 |
| DRAJKA-KROPACZEK, L; HORNUNG, S; POLONCZYK, M; RAPF, T | 1 |
| GACKOWSKI, J; KOSTRZENSKI, W; PAKLERSKA POBRATYN, H; SYROWATKA, T | 1 |
| ARITA, T; KAKEMI, K; SEZAKI, H; SUGIMOTO, I | 1 |
| Fischetti, JL; Rein, MF; Sande, MA | 1 |
| Ahmed, I; Obaideen, AM; Rahman, NU; Shahat, AH; Zahman Au, Au | 1 |
| Chen, DC; Feng, YG; Jia, JJ | 1 |
19 other study(ies) available for salicylic acid and isoniazid
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening.
Topics: Bacterial Proteins; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fatty Acid Synthases; Molecular Structure; Mycobacterium tuberculosis; ortho-Aminobenzoates; Structure-Activity Relationship | 2020 |
Therapy of pulmonary tuberculosis with isoniazid alone and in combination with streptomycin and with para-amino-salicylic acid.
Topics: Amino Acids; Aminosalicylic Acid; Isoniazid; Salicylic Acid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
[Certain derivatives of isonicotinic acid hydrazide; isonicotinic acid hydrazide sodium methylsulfonate, pyruvic acid isonicotinylhydrazone, salicylic acid isonicotinylhydrazone; bacteriological data].
Topics: Isomerism; Isoniazid; Mesylates; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyruvic Acid; Salicylic Acid; Sodium; Sodium, Dietary | 1955 |
Treatment of pulmonary tuberculosis on a combined regimen of para-amino-salicylic acid, streptomycin and isonicotinic acid hydrazide.
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Salicylic Acid; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[On the behavior of the p-amino-salicylic acid and isonicotinic acid hydrazid system in aqueous solutions].
Topics: Amino Acids; Aminosalicylic Acid; Isoniazid; Isonicotinic Acids; Salicylic Acid | 1960 |
Hypersensitivity reactions to streptomycin, para-amino-salicylic acid and hydrazide.
Topics: Amino Acids; Aminosalicylic Acid; Anti-Bacterial Agents; Hypersensitivity; Isoniazid; Salicylic Acid; Streptomycin | 1959 |
Metabolism of isoniazid and para-amino salicylic acid (PAS) in the organism and its therapeutic significance.
Topics: Amino Acids; Aminosalicylic Acid; Female; Humans; Isoniazid; Parity; Salicylic Acid | 1962 |
The action of bromosalicylhydroxamic acid (T40) on the biological level of INH and on the emergence of INH-resistant bacilli in combined treatment of tuberculosis.
Topics: Bacillus; Drug Resistance; Drug Resistance, Microbial; Humans; Hydroxamic Acids; Isoniazid; Salicylic Acid; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
STUDIES OF A NEW TUBERCULOSTATIC COMPOUND FROM THE GROUP OF ARYLIDES OF AROMATIC HYDROXYACIDS.
Topics: Anilides; Antitubercular Agents; Aspergillus; Bacillus megaterium; Bacillus subtilis; Basidiomycota; Candida; Escherichia coli; Fusarium; Guinea Pigs; Isoniazid; Mycobacterium; Mycobacterium tuberculosis; Penicillium; Pharmacology; Proteus; Pseudomonas aeruginosa; Research; Saccharomyces; Salicylic Acid; Streptomycin; Toxicology; Trichophyton | 1964 |
[STUDIES ON SUCROSE ESTERS. 3. EFFECT OF SUCROSE ESTERS ON THE ABSORPTION OF DRUGS FROM THE ALIMENTARY TRACT].
Topics: Esters; Intestinal Absorption; Isoniazid; Pharmacology; Rats; Research; Salicylic Acid; Stearic Acids; Sucrose; Sulfanilamide; Sulfanilamides; Surface-Active Agents; Tetracycline | 1964 |
Osteomyelitis caused by concurrent infection with Mycobacterium tuberculosis and Blastomyces dermatitidis.
Topics: Amphotericin B; Blastomyces; Blastomycosis; Diagnostic Errors; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Osteomyelitis; Sacrum; Scalp; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary | 1974 |
Cranial-epidural tuberculosis presenting as a scalp swelling.
Topics: Adult; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Edema; Epidural Space; Ethambutol; Frontal Bone; Humans; Isoniazid; Magnetic Resonance Imaging; Male; Parietal Bone; Pyrazinamide; Rifampin; Scalp; Tomography, X-Ray Computed; Tuberculosis, Osteoarticular | 2004 |
A 9-year massive scrofuloderma of the scalp cured in 3 months.
Topics: Antitubercular Agents; Biopsy; Diagnostic Errors; Drug Therapy, Combination; Humans; Isoniazid; Male; Methylprednisolone; Middle Aged; Necrobiotic Xanthogranuloma; Rifampin; Scalp; Skin; Time Factors; Treatment Outcome; Tuberculin Test; Tuberculosis, Cutaneous | 2019 |